Evidence map›Paper›PMID 29955175›Full record

ArticleCellular & molecular immunology2019

An altered CD8

Mengjun Zhang, Shufeng Wang, Binbin Guo, Gang Meng, Chi Shu, Wenli Mai, Qian Zheng, Xiaoling Chen, Yuzhang Wu, Li Wang

Open access · bronzeAbstract read
In one paragraph

Article in Cellular & molecular immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Analysis of frequency changes in CD8Diabetology & metabolic syndrome · 2024
    Article
  2. Article
  3. Review
  4. Review
  5. A Single L/D-Substitution at Q4 of the mInsAFrontiers in immunology · 2021
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mengjun ZhangDepartment of Pharmaceutical Analysis, College of Pharmacy, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Shufeng WangInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Binbin GuoInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Gang MengDepartment of Pathology, Southwest Hospital, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Chi ShuInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Wenli MaiInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Qian ZhengInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Xiaoling ChenInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Yuzhang WuInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Li WangInstitute of Immunology PLA & Department of Immunology, Army Medical University (Third Military Medical University), 400038, Chongqing, China. liwang118@icloud.com.
Army Medical University · CNNorth Sichuan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoreactive CD8

Indexed as

AnimalsCells, CulturedClonal AnergyDiabetes Mellitus, Type 1Epitopes, T-LymphocyteForkhead Transcription FactorsHLA-A2 AntigenHumansInsulinMiceMice, Inbred NODMutagenesis, Site-DirectedPancreasPeptidesT-Lymphocytes, RegulatoryEpitopes, T-LymphocyteForkhead Transcription FactorsFoxp3 protein, mouseHLA-A*02:01 antigenHLA-A2 AntigenInsulinPeptidesAltered peptide ligandCD8+CD25+Foxp3+ regulatory T cellsInsB15–14NOD.β2m null .HHD miceType 1 diabetes

Identifiers

PMID29955175
PMCPMC6804845
OpenAlexW2810054659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.